The Israel Institute for Biological Research on Monday announced it is beginning the second phase of human trials for a coronavirus vaccine.
The second phase will include 1,000 volunteers and will begin at the Hadassah Medical Center in Jerusalem initially and expand to other hospitals around the country.

